Core Viewpoint - A class action lawsuit has been filed against Quantum Biopharma Ltd. for alleged securities fraud and unlawful business practices, with a deadline for investors to join the lawsuit by February 23, 2026 [1]. Group 1: Lawsuit Details - The lawsuit is on behalf of shareholders of Quantum Biopharma Ltd. and involves allegations that the company and certain officers engaged in securities fraud [1]. - Investors are encouraged to contact Pomerantz LLP to join the class action and are advised to provide their contact information and number of shares purchased [1]. Group 2: Allegations Against Defendants - The complaint alleges that several financial institutions, including CIBC World Markets and RBC Capital Markets, executed thousands of spoofed sell orders to create a false impression of Quantum's stock price decline [1]. - These manipulative orders were intended to deceive investors into selling their shares at artificially low prices, allowing the defendants to purchase shares at these depressed levels for profit [1].